Goldman Sachs’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
116,348
-117,174
| -50% | -$305K | ﹤0.01% | 4521 |
|
|
2025
Q1 | $444K | Sell |
233,522
-156,917
| -40% | -$298K | ﹤0.01% | 4318 |
|
|
2024
Q4 | $566K | Buy |
390,439
+19,310
| +5% | +$28K | ﹤0.01% | 4236 |
|
|
2024
Q3 | $683K | Buy |
371,129
+135,623
| +58% | +$250K | ﹤0.01% | 3959 |
|
|
2024
Q2 | $236K | Buy |
235,506
+112,794
| +92% | +$113K | ﹤0.01% | 4298 |
|
|
2024
Q1 | $243K | Sell |
122,712
-83,885
| -41% | -$166K | ﹤0.01% | 4270 |
|
|
2023
Q4 | $322K | Sell |
206,597
-13,585
| -6% | -$21.2K | ﹤0.01% | 4146 |
|
|
2023
Q3 | $434K | Buy |
220,182
+112,626
| +105% | +$222K | ﹤0.01% | 3939 |
|
|
2023
Q2 | $342K | Sell |
107,556
-90,966
| -46% | -$289K | ﹤0.01% | 4173 |
|
|
2023
Q1 | $649K | Buy |
+198,522
| New | +$649K | ﹤0.01% | 3936 |
|